Bambusa Therapeutics, Inc. Common Stock

BBTX

Capitalización de mercado USD 801 M

15.73 USD

-0.12

0.76%

Al cierre Actualizado 6 nov, 4:00 p.m. EST

1 día

-0.76%

5 días

4.94%

1 mes

4.94%

3 meses

4.94%

6 meses

4.94%

En lo que va del año

4.94%

1 año

4.94%

5 años

4.94%

10 años

4.94%

Acerca de: Bambusa Therapeutics Inc is a clinical-stage biotechnology company developing a portfolio of next-generation, multi-targeting medicines designed to transform patient care across chronic immunology and inflammation diseases.

Salud Biotecnología

Noticias

Positivo

Neutral

Negativo

Sentimiento 3 meses

Positivo 0%

Neutral 100%

Negativo 0%

Neutral

Seeking Alpha

hace 8 días

U.S. IPO Weekly Recap: Anthropic Files For Potentially Record-Breaking IPO

Three IPOs, one direct listing, and two SPACs priced during a challenging week for growth stocks. Just one SPAC is currently scheduled to list in the week ahead, although some smaller deals may also join the calendar throughout the week. Street research is expected for two companies in the week ahead, and six lock-up periods will be expiring.

Ver rankings de noticias

Gráficos de precios implementados con Lightweight Charts™

Bambusa Therapeutics, Inc. Common Stock BBTX Capitalización de mercado USD 801 M

Noticias

Bambusa Therapeutics, Inc. Common Stock

BBTX

Capitalización de mercado USD 801 M